Abstract
Despite a major decline in incidence and mortality over several decades, stomach cancer is still the fourth most common cancer and the second most common cause of cancer death in the world. There is a 10-fold variation in incidence between populations at the highest and lowest risk. The incidence is particularly high in East Asia, Eastern Europe, and parts of Central and South America, and it is about twice as high among men than among women. Prognosis is generally rather poor, with 5-year relative survival below 30% in most countries. The best established risk factors for stomach cancer are Helicobacter pylori infection, the by far strongest established risk factor for distal stomach cancer, and male sex, a family history of stomach cancer, and smoking. While some factors related to diet and food preservation, such as high intake of salt-preserved foods and dietary nitrite or low intake of fruit and vegetables, are likely to increase the risk of stomach cancer, the quantitative impact of many dietary factors remains uncertain, partly due to limitations of exposure assessment and control for confounding factors. Future epidemiologic research should pay particular attention to differentiation of stomach cancer epidemiology by subsite, and to exploration of potential interactions between H. pylori infection, genetic, and environmental factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ferlay, J., Bray, F., Pisani, P., and Parkin, D. M. (2004) GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5. Version 2.0, IARC Press, Lyon, France [online available from http://www-dep.iarc.fr]
International Agency for Research on Cancer, World Health Organization (1994) Infection with Helicobacter pylori, in Schistosomes, liver flukes and Helicobacter pylori, IARC Monogr. Eval. Carcinog. Risks Hum. Vol. 60, Lyon, France, pp. 177–240.
Campbell, D. I., Warren, B. F., Thomas, J. E., Figura, N., Telford, J. L., and Sullivan, P. B. (2001) The African enigma: low prevalence of gastric atrophy, high prevalence of chronic inflammation in West African adults and children.Helicobacter.6, 263–267.
Brenner, H. (2002) Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis.Lancet 360, 1131–1135.
Parkin, D. M., Bray, F., Ferlay, J., and Pisani, P. (2005) Global cancer statistics, 2002.CA Cancer J. Clin.55, 74–108.
Forman, D. and Burley, V. J. (2006) Gastric cancer: global pattern of the disease and an overview of environmental risk factors.Best Pract. Res. Clin. Gastroenterol.20, 633–649.
Parkin, D. M., Whelan, S. L., Ferlay, J., and Storm, H. (2005) Cancer incidence in five continents, Vol I to VIII, IARC CancerBase No. 7, IARC Press, Lyon, France [online available fromhttp://www-dep.iarc.fr
Berrino, F. (2003) The EUROCARE Study: strengths, limitations and perspectives of population-based, comparative survival studies.Ann. Oncol.14Suppl 5, v9–13.
Gatta, G., Capocaccia, R., Coleman, M. P., Gloeckler Ries, L. A., Hakulinen, T., Micheli, A., Sant, M., Verdecchia, A., and Berrino, F. (2000) Toward a comparison of survival in American and European cancer patients.Cancer 89, 893–900.
Verdecchia, A., Mariotto, A., Gatta, G., Bustamante-Teixeira, M. T., and Ajiki, W. (2003) Comparison of stomach cancer incidence and survival in four continents.Eur. J. Cancer 39, 1603–1609.
Crew, K. D. and Neugut, A. I. (2006) Epidemiology of gastric cancer.World J. Gastroenterol.12, 354–362.
Banatvala, N., Mayo, K., Megraud, F., Jennings, R., Deeks, J. J., and Feldman, R. A. (1993) The cohort effect andHelicobacter pylori. J. Infect. Dis. 168, 219–221.
Roosendaal, R., Kuipers, E. J., Buitenwerf, J., van Uffelen, C., Meuwissen, S. G., van Kamp, G. J., and Vandenbroucke-Grauls, C. M. (1997)Helicobacter pyloriand the birth cohort effect: evidence of a continuous decrease of infection rates in childhood.Am. J. Gastroenterol.92, 1480–1482.
Marshall, B. J. and Warren, J. R. (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.Lancet 1, 1311–1315.
Helicobacter pylori and Cancer Collaborative Group (2001) Gastric cancer andHelicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts.Gut 49, 347–353.
Ekström, A. M., Held, M., Hansson, L. E., Engstrand, L., and Nyren, O. (2001)Helicobacter pyloriin gastric cancer established by CagA immunoblot as a marker of past infection.Gastroenterology 121, 784–791.
Brenner, H., Arndt, V., Stegmaier, C., Ziegler, H., and Rothenbacher, D. (2004) IsHelicobacter pyloriinfection a necessary condition for noncardia gastric cancer?Am. J. Epidemiol.159, 252–258.
Rothenbacher, D. and Brenner, H. (2003) Burden ofHelicobacter pyloriandH. pylori-related diseases in developed countries: recent developments and future implications.Microbes Infect. 5, 693–703.
Huang, J. Q., Zheng, G. F., Sumanac, K., Irvine, E. J., and Hunt, R. H. (2003) Metaanalysis of the relationship between cagA seropositivity and gastric cancer.Gastroen-terology 125, 1636–1644.
El-Omar, E. M., Rabkin, C. S., Gammon, M. D., Vaughan, T. L., Risch, H. A., Sch-oenberg, J. B., Stanford, J. L., Mayne, S. T., Goedert, J., Blot, W. J., Fraumeni, J. F., Jr., and Chow, W. H. (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms.Gastroenterology 124, 1193–1201.
Brenner, H., Arndt, V., Bode, G., Stegmaier, C., Ziegler, H., and Stumer, T. (2002) Risk of gastric cancer among smokers infected withHelicobacter pylori. Int. J. Cancer 98, 446–449.
Brenner, H., Arndt, V., Stürmer, T., Steg-maier, C., Ziegler, H., and Dhom, G. (2000) Individual and joint contribution of family history andHelicobacter pyloriinfection to the risk of gastric carcinoma.Cancer 88, 274–279.
Rothenbacher, D., Inceoglu, J., Bode, G., and Brenner, H. (2000) Acquisition ofHeli-cobacter pyloriinfection in a high-risk population occurs within the first 2 years of life.J. Pediatr. 136, 744–748.
Rothenbacher, D., Bode, G., and Brenner, H. (2002) Dynamics ofHelicobacter pyloriinfection in early childhood in a high-risk group living in Germany: loss of infection higher than acquisition.Aliment. Pharmacol. Ther. 16, 1663–1668.
Weyermann, M., Adler, G., Brenner, H., and Rothenbacher, D. (2006) The mother as source ofHelicobacter pyloriinfection.Epidemiology 17, 332–334.
Wong, B. C., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H., Yuen, S. T., Leung, S. Y., Fong, D. Y., Ho, J., Ching, C. K., and Chen, J. S. (2004)Helicobacter pylorieradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.JAMA 291, 187–194.
Fuccio, L., Zagari, R. M., Minardi, M. E., and Bazzoli, F. (2007) Systematic review:Helicobacter pylorieradication for the prevention of gastric cancer.Aliment. Pharmacol. Ther. 25, 133–141.
Kamineni, A., Williams, M. A., Schwartz, S. M., Cook, L. S., and Weiss, N. S. (1999) The incidence of gastric carcinoma in Asian migrants to the United States and their descendants.Cancer Causes Control 10, 77–83.
Jakszyn, P. and Gonzalez, C. A. (2006) Nit-rosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence.World J. Gastroenterol.12, 4296–4303.
Riboli, E. and Norat, T. (2003) Epidemio-logic evidence of the protective effect of fruit and vegetables on cancer risk.Am. J. Clin. Nutr. 78, 559S–569S.
Gonzalez, C. A., Pera, G., Agudo, A., Bueno-de-Mesquita, H. B., Ceroti, M., Boeing, H., Schulz, M., Del Giudice, G., Plebani, M., Carneiro, F., Berrino, F., Sacer-dote, C., Tumino, R., Panico, S., Berglund, G., Siman, H., Hallmans, G., Stenling, R., Martinez, C., Dorronsoro, M., Barricarte, A., Navarro, C., Quiros, J. R., Allen, N., Key, T. J., Bingham, S., Day, N. E., Lin-seisen, J., Nagel, G., Overvad, K., Jensen, M. K., Olsen, A., Tjonneland, A., Buchner, F. L., Peeters, P. H., Numans, M. E., Clavel-Chapelon, F., Boutron-Ruault, M. C., Rou-kos, D., Trichopoulou, A., Psaltopoulou, T., Lund, E., Casagrande, C., Slimani, N., Jenab, M., and Riboli, E. (2006) Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST).Int. J. Cancer 118, 2559–2566.
Gonzalez, C. A., Jakszyn, P., Pera, G., Agudo, A., Bingham, S., Palli, D., Ferrari, P., Boeing, H., del Giudice, G., Plebani, M., Carneiro, F., Nesi, G., Berrino, F., Sacer-dote, C., Tumino, R., Panico, S., Berglund, G., Siman, H., Nyren, O., Hallmans, G., Martinez, C., Dorronsoro, M., Barricarte, A., Navarro, C., Quiros, J. R., Allen, N., Key, T. J., Day, N. E., Linseisen, J., Nagel, G., Bergmann, M. M., Overvad, K., Jensen, M. K., Tjonneland, A., Olsen, A., Bueno-de-Mesquita, H. B., Ocke, M., Peeters, P. H., Numans, M. E., Clavel-Chapelon, F., Boutron-Ruault, M. C., Trichopoulou, A., Psaltopoulou, T., Roukos, D., Lund, E., Hemon, B., Kaaks, R., Norat, T., and Riboli, E. (2006) Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC).J. Natl. Cancer Inst. 98, 345–354.
Jacobs, E. J., Connell, C. J., McCullough, M. L., Chao, A., Jonas, C. R., Rodriguez, C., Calle, E. E., and Thun, M. J. (2002) Vitamin C, vitamin E, and multivitamin supplement use and stomach cancer mortality in the Cancer Prevention Study II cohort.Cancer Epidemiol. Biomarkers Prev. 11, 35–41.
Gonzalez, C. A., Pera, G., Agudo, A., Palli, D., Krogh, V., Vineis, P., Tumino, R., Pan-ico, S., Berglund, G., Siman, H., Nyren, O., Agren, A., Martinez, C., Dorronsoro, M., Barricarte, A., Tormo, M. J., Quiros, J. R., Allen, N., Bingham, S., Day, N., Miller, A., Nagel, G., Boeing, H., Overvad, K., Tjonneland, A., Bueno-De-Mesquita, H. B., Boshuizen, H. C., Peeters, P., Numans, M., Clavel-Chapelon, F., Helen, I., Agapi-tos, E., Lund, E., Fahey, M., Saracci, R., Kaaks, R., and Riboli, E. (2003) Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).Int. J. Cancer 107, 629–634.
Brinton, L. A., Gridley, G., Hrubec, Z., Hoover, R., and Fraumeni, J. F., Jr. (1989) Cancer risk following pernicious anaemia.Br. J. Cancer 59, 810–813.
Wang, W. H., Huang, J. Q., Zheng, G. F., Lam, S. K., Karlberg, J., and Wong, B. C. (2003) Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis.J. Natl. Cancer Inst. 95, 1784–1791.
Brenner, H., Bode, G., and Boeing, H. (2000)Helicobacter pyloriinfection among offspring of patients with stomach cancer.Gastroenterology 118, 31–35.
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., and Thun, M. J. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.N. Engl. J. Med. 348, 1625–1638.
Raj, A., Mayberry, J. F., and Podas, T. (2003) Occupation and gastric cancer.Postgrad. Med. J. 79, 252–258.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Brenner, H., Rothenbacher, D., Arndt, V. (2009). Epidemiology of Stomach Cancer. In: Verma, M. (eds) Cancer Epidemiology. Methods in Molecular Biology, vol 472. Humana Press. https://doi.org/10.1007/978-1-60327-492-0_23
Download citation
DOI: https://doi.org/10.1007/978-1-60327-492-0_23
Publisher Name: Humana Press
Print ISBN: 978-1-60327-491-3
Online ISBN: 978-1-60327-492-0
eBook Packages: Springer Protocols